umuD Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
umuD antibody; b1183 antibody; JW1172Protein UmuD antibody; EC 3.4.21.- antibody; DNA polymerase V antibody; Pol V) [Cleaved into: Protein UmuD'] antibody
Target Names
umuD
Uniprot No.

Target Background

Function

This antibody targets DNA polymerase V (Pol V), a poorly processive, error-prone enzyme crucial for translesion DNA synthesis (TLS) and UV protection. Pol V is involved in the SOS response, a bacterial DNA repair mechanism, enabling replication across DNA lesions such as thymine dimers and abasic sites. Its activity is significantly enhanced by RecA, the β sliding clamp, the DNA polymerase III clamp-loading complex, and single-stranded binding protein (SSB). These factors likely recruit Pol V to stalled replication forks.

Gene References Into Functions

Pol V regulation is multifaceted, encompassing transcriptional control, post-translational modifications, targeted proteolysis, modulation of catalytic activity through protein interactions, and recent findings indicating intracellular spatial regulation. Numerous studies have illuminated various aspects of Pol V function and regulation:

  • Regulation of Pol V: A review detailing the various levels of Pol V regulation (PMID: 27236212)
  • RecA-UmuD'2C interaction: Research investigating the molecular interaction between RecA and UmuD'2C (PMID: 25811184)
  • UmuD'2C cleavage: Demonstration of RecA's role in the cleavage of UmuD'2C, similar to the self-cleavage of LexA and UmuD (PMID: 22697494)
  • UmuD'2C structural dynamics: An EPR spectroscopy study examining the structural flexibility and dynamics of UmuD'2C (PMID: 21975937)
  • N-terminal residue mutations: The effects of N-terminal mutations on UV sensitivity and mutagenesis (PMID: 21784925)
  • UmuD'2C dimerization: Studies showing the impact of a single amino acid change (N41D) on UmuD'2C dimerization and function (PMID: 21118802)
  • Pol V properties and functions: A review of Pol V properties and functions (PMID: 15588845)
  • Pol V in DNA repair: The role of Pol V in translesion synthesis and protection of stalled replication forks (PMID: 16199565)
  • Pol V lyase activity: Evidence for intrinsic lyase activity in Pol V (PMID: 16202661)
  • Pol V in MMS-induced mutagenesis: The roles of AlkB, Pol V, and AlkA in preventing MMS-induced mutagenesis (PMID: 16226494)
  • Novel UmuD variants: Discovery of novel UmuD variants that mimic the cleaved form, UmuD' (PMID: 16464848)
  • UmuD structural characteristics: Structural features of UmuD and their role in regulating the SOS response (PMID: 18216271)
Database Links

KEGG: ecj:JW1172

STRING: 511145.b1183

Protein Families
Peptidase S24 family

Q&A

What is the UmuD protein and why is it significant for bacterial mutagenesis research?

UmuD is a critical protein in Escherichia coli's SOS response to DNA damage. Following treatment with replication-inhibiting agents such as UV light, E. coli's mutation rate increases approximately 100-fold, a process requiring the action of UmuD and UmuC proteins . UmuD undergoes RecA-mediated cleavage, converting it from the 17 kDa full-length form to the 14 kDa processed form (UmuD'), which activates it for mutagenic function . This processing represents a critical regulatory step in SOS mutagenesis, making UmuD antibodies valuable tools for studying DNA damage response mechanisms.

How are UmuD antibodies typically generated and what are their key characteristics?

UmuD antibodies are typically polyclonal antibodies raised in rabbits against highly purified, full-length recombinant UmuD protein from E. coli . Commercial antibodies like those from Agrisera (AS21 4546) are produced using the full-length protein corresponding to UniProt: P0AG11 . These antibodies recognize both the intact (17 kDa) and processed (14 kDa) forms of UmuD, allowing researchers to monitor the cleavage reaction critical for mutagenic activation.

What methods can be used to validate the specificity of anti-UmuD antibodies?

Table 1: Validation Methods for Anti-UmuD Antibodies

Validation MethodProcedureExpected ResultsControls Required
Western BlotCompare untreated vs. mitomycin C-treated E. coliIncreased signal at 17 kDa (intact) and 14 kDa (processed) in treated samplesE. coli DE274 (lexA51, recA730) strain
Recombinant ProteinProbing purified recombinant UmuDSingle band at 17 kDaIrrelevant recombinant protein
Genetic KnockoutProbing ΔumuD E. coli strainsNo signal at expected MWWild-type E. coli
Cross-adsorptionPreincubation with purified UmuD proteinSignal abolishmentNon-preincubated antibody
ImmunoprecipitationIP followed by mass spectrometryIdentification of UmuD proteinIP with pre-immune serum

How can UmuD antibodies be optimally used to study protein-protein interactions in the SOS pathway?

UmuD antibodies are valuable tools for studying protein interactions within the SOS mutagenesis pathway. Immunoprecipitation experiments have demonstrated that antibodies to UmuC precipitate UmuD' from cell extracts, and antibodies to UmuD/UmuD' precipitate UmuC, confirming their in vivo association . For optimal co-immunoprecipitation experiments:

  • Lyse cells in non-denaturing buffers (e.g., 50 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40)

  • Pre-clear lysates with protein A/G beads

  • Incubate with anti-UmuD antibody (recommended dilution 1:50 for IP)

  • Capture complexes with protein A/G beads

  • Wash extensively (minimum 5 washes)

  • Analyze by Western blot using antibodies against suspected interaction partners

Biochemical studies have shown that UmuC associates strongly with UmuD/UmuD', eluting from affinity columns only under strongly dissociating conditions (2 M urea or 1.5 M KSCN) , suggesting researchers should use stringent conditions when attempting to dissociate these complexes.

What experimental design considerations are crucial when using UmuD antibodies to monitor DNA damage responses?

Table 2: Experimental Design Parameters for UmuD Antibody Studies

ParameterRecommended RangeOptimization ApproachImpact on Results
DNA Damage AgentMitomycin C (1-10 μg/mL) or UV (5-50 J/m²)Dose-response curveDifferent agents may induce varying UmuD expression patterns
Time Course0-120 minutes post-treatmentMultiple timepointsCaptures dynamics of UmuD expression and processing
Protein ExtractionNative vs. denaturingCompare both methodsNative preserves interactions; denaturing improves yield
Antibody Dilution1:1000 to 1:5000 (WB)Titration experimentOptimal signal-to-noise ratio
Detection SystemChemiluminescence vs. fluorescenceSide-by-side comparisonDifferent sensitivities and dynamic ranges
Statistical DesignMinimum 3 biological replicatesPower analysisEnsures statistical significance

A design of experiment (DOE) approach can significantly improve assay robustness . By systematically varying key parameters and measuring their impact on signal strength and specificity, researchers can identify optimal conditions for their specific experimental system.

What advanced techniques can be combined with UmuD antibodies to gain deeper insights into the SOS response?

Beyond standard Western blotting, UmuD antibodies can be integrated into several advanced techniques:

  • Chromatin Immunoprecipitation (ChIP): If UmuD associates with DNA (directly or indirectly), ChIP using UmuD antibodies followed by sequencing can identify genomic binding sites.

  • Proximity Ligation Assay (PLA): Combining UmuD antibodies with antibodies against other SOS proteins (e.g., RecA or UmuC) in PLA can visualize protein interactions in situ with high sensitivity.

  • Super-resolution microscopy: Immunofluorescence with UmuD antibodies, combined with techniques like STORM or PALM, can reveal the subcellular localization and clustering of UmuD with nanometer precision.

  • Mass spectrometry: Immunoprecipitation with UmuD antibodies followed by MS analysis can identify novel interaction partners and post-translational modifications.

  • Single-cell analysis: Flow cytometry using permeabilized cells and fluorescently-labeled UmuD antibodies can reveal cell-to-cell variation in the SOS response .

How can computational approaches enhance UmuD antibody development and application?

Recent advances in computational protein design have transformed antibody engineering. For UmuD research, computational approaches offer several advantages:

  • Epitope prediction and optimization: Computational tools can identify optimal epitopes on UmuD for antibody generation, particularly regions that distinguish between cleaved and uncleaved forms.

  • Antibody engineering: Using tools like RFdiffusion , researchers can design novel antibodies with high specificity for UmuD. This approach allows "atomically accurate de novo design of antibodies" that bind to specific epitopes with precise binding poses.

  • Large-scale sequence analysis: By mining public repositories of antibody sequences (like the AbNGS database with four billion productive human heavy variable region sequences ), researchers can identify patterns and conserved motifs for optimal antibody design.

  • Structural modeling: Computational modeling of UmuD-antibody complexes can predict binding affinity and specificity, guiding the selection of optimal antibody candidates before experimental validation.

What are the most common technical challenges when working with UmuD antibodies and how can they be resolved?

Table 3: Troubleshooting Guide for UmuD Antibody Experiments

ProblemPossible CausesSolutionsPrevention Strategies
No signal in Western blotInsufficient SOS inductionIncrease DNA damage agent concentrationPerform preliminary time-course and dose-response studies
Protein degradationAdd protease inhibitors during extractionProcess samples quickly, keep cold
Poor transferOptimize transfer conditions for small proteinsUse PVDF membrane for proteins <20 kDa
High backgroundInsufficient blockingIncrease blocking time/concentrationOptimize blocking buffer composition
Non-specific antibody bindingUse higher antibody dilutionInclude Fc receptor blocking reagents
Multiple unexpected bandsCross-reactivity with LexAPerform competition assays with purified proteinsUse epitope-mapped antibodies
Non-specific binding to Fc receptorsInclude Fc blocking agentsPre-clear lysates thoroughly
Poor reproducibilityVariability in DNA damage inductionStandardize treatment protocolsInclude internal controls
Batch-to-batch antibody variationUse recombinant antibodiesPerform quality control on each antibody lot

How should flow cytometry protocols be optimized for UmuD antibody-based assays?

When adapting UmuD antibodies for flow cytometry applications, several critical factors must be addressed:

  • Cell fixation and permeabilization: Since UmuD is an intracellular protein, proper permeabilization is essential. Test multiple permeabilization reagents (e.g., saponin, Triton X-100, methanol) to determine which provides optimal antibody access while preserving epitope recognition.

  • Blocking strategy: Non-specific binding can significantly impact flow cytometry results. A dual blocking approach is recommended: first block Fc receptors with purified IgG-Fc fragment , then block with a protein-based blocking agent (BSA or serum).

  • Antibody titration: Perform a detailed titration series (typically 1:50 to 1:5000) to identify the optimal antibody concentration that provides maximum signal-to-noise ratio.

  • Controls: Essential controls include:

    • Isotype control antibodies

    • Secondary antibody-only controls

    • Uninduced cells (negative control)

    • Strongly induced cells (positive control)

    • Compensation controls if using multiple fluorophores

  • Data analysis: For quantitative analysis, convert fluorescence intensity to molecules of equivalent soluble fluorochrome (MESF) using calibration beads, which allows standardization across experiments and instruments.

What statistical approaches are most appropriate for analyzing UmuD expression data across multiple experimental conditions?

For robust statistical analysis of UmuD antibody data:

  • Power analysis: Before beginning experiments, conduct power analysis to determine the minimum sample size needed to detect anticipated effect sizes with statistical significance.

  • Normalization strategies:

    • For Western blot data: Normalize to housekeeping proteins like GAPDH or total protein (measured by Ponceau S staining)

    • For flow cytometry: Use internal standards and MESF calibration beads

  • Statistical tests:

    • For comparing two conditions: Paired t-test or Wilcoxon signed-rank test (if non-normally distributed)

    • For multiple conditions: One-way ANOVA followed by post-hoc tests (Tukey's or Dunnett's)

    • For time-course data: Repeated measures ANOVA or mixed-effects models

  • Multivariate analysis: When examining multiple parameters (e.g., UmuD expression, cleavage ratio, cell viability), principal component analysis (PCA) or partial least squares discriminant analysis (PLS-DA) can identify patterns and correlations.

  • Reporting standards: Report both effect sizes and p-values, and consider implementing the optimal design of experiments (DOE) approach described in several studies to maximize statistical power.

How can researchers accurately quantify the ratio of full-length to cleaved UmuD and what does this ratio signify?

Table 4: Interpretation Guide for UmuD/UmuD' Ratio Analysis

UmuD/UmuD' RatioCellular StateBiological SignificanceTime Point After SOS Induction
>5:1Early SOS responseInitial UmuD production, limited cleavage0-30 minutes
2:1 - 5:1Active SOS responseOngoing UmuD production and processing30-60 minutes
1:1 - 2:1Peak mutagenic potentialBalance between production and processing60-90 minutes
<1:1Late SOS responsePredominant UmuD' form, high mutagenic potential>90 minutes

For accurate quantification, densitometric analysis of Western blots should be performed using analysis software that can discriminate between the 17 kDa (UmuD) and 14 kDa (UmuD') bands. Calibration with purified recombinant proteins of known concentration can convert band intensities to absolute protein quantities.

The ratio of UmuD to UmuD' provides critical information about the activation state of the SOS mutagenesis pathway. As demonstrated in biochemical studies, RecA-mediated cleavage of UmuD to UmuD' is required for activation of the mutagenic function . Therefore, an increasing proportion of UmuD' indicates progression toward maximum mutagenic potential.

What considerations are important when integrating UmuD antibody data with other omics approaches?

When combining UmuD antibody data with other omics techniques:

  • Temporal alignment: Ensure sampling timepoints are synchronized across different omics platforms to capture the true relationship between UmuD processing and other molecular events.

  • Data integration approaches:

    • Correlation networks linking UmuD/UmuD' levels with transcriptomic changes

    • Pathway enrichment analysis to identify processes coregulated with UmuD activation

    • Machine learning models incorporating UmuD data with other omics variables to predict mutagenic outcomes

  • Validation strategies:

    • Genetic approaches (umuD mutants, overexpression)

    • Orthogonal protein detection methods (mass spectrometry)

    • Functional assays correlating UmuD processing with mutation frequency

  • Data visualization: Use integrated visualization tools that can represent multiple data types simultaneously, such as Circos plots, heatmaps with hierarchical clustering, or network diagrams showing protein-protein interactions centered on UmuD/UmuC.

  • Public data repositories: Consider how your UmuD antibody data can be formatted for submission to public repositories to enable meta-analyses across multiple studies, enhancing the impact and reproducibility of your findings.

How might next-generation antibody technologies enhance UmuD research?

Recent advances in antibody engineering offer exciting possibilities for UmuD research:

  • Single-domain antibodies: Nanobodies or single-domain antibodies derived from camelids could provide superior access to conformation-specific epitopes on UmuD, potentially distinguishing subtle structural changes during activation.

  • Bispecific antibodies: These could simultaneously target UmuD and interaction partners like UmuC, providing more direct evidence of protein complexes in situ .

  • Intrabodies: Antibody fragments expressed intracellularly could track UmuD localization and interactions in living cells without fixation artifacts.

  • Format engineering: Converting conventional antibodies to different formats (Fab, scFv, etc.) can optimize performance for specific applications .

  • Antibody reformatting: Species switching or isotype switching could enhance compatibility with different experimental systems while maintaining epitope specificity .

What experimental design principles should be applied when developing novel applications for UmuD antibodies?

When designing experiments for novel UmuD antibody applications:

  • Apply DOE methodology: Systematic experimental design approaches have proven valuable for antibody research , allowing researchers to:

    • Identify critical parameters affecting assay performance

    • Establish robust design spaces for reproducible results

    • Minimize resource usage while maximizing information gain

  • Establish proper controls:

    • Positive controls (DNA damage-induced samples)

    • Negative controls (umuD knockout strains)

    • Technical controls (secondary antibody only, isotype controls)

  • Consider sample size and power:

    • Perform preliminary studies to estimate effect sizes

    • Conduct power analysis to determine optimal sample numbers

    • Include biological (not just technical) replicates

  • Address confounding factors:

    • Batch effects from antibody production

    • Growth phase variations in bacterial cultures

    • Environmental factors affecting the SOS response

  • Ensure reproducibility:

    • Standardize protocols with detailed SOPs

    • Report all experimental conditions comprehensively

    • Share reagents and validation data with the research community

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.